跳至主要内容
临床试验/CTRI/2021/07/035281
CTRI/2021/07/035281进行中(未招募)未知

Evaluating the Use of Blood based Real Time Polymerase Chain Reaction Testing for Early Detection and Monitoring of Mucormycosis.

Datar Cancer Genetics Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • ââ?¬Â¢High risk patients (patients with prolonged severe neutropenia, receiving corticosteroids or T-cell suppressor, recipients of allogeneic Hematopoietic stem-cell transplantation (HSCT), or inherited severe immunodeficiency)
  • ââ?¬Â¢Patients with other predisposing factors of invasive mould disease (Uncontrolled blood sugars, known diabetic on steroids , Acquired immunodeficiency syndrome (AIDS), haematological malignancies or solid tumours, prolonged Intensive Care Unit, or hospital stay abnormal D Dimer test).
  • ââ?¬Â¢Patients already diagnosed with probable or proven mucormycosis irrespective of underlying conditions, including patients referred from other centers.

排除标准

  • ââ?¬Â¢Presence of any medical condition that would not allow collection of blood samples for the Real-time polymerase chain reaction test.
  • ââ?¬Â¢History of documented, successfully treated, prior Mucormycosis.

研究者

相似试验